The present study investigated the antiglycation activities of extracts and fractions of Phyllanthus amarus, Chrysanthellum americanum, Striga hermonthica and, based on cytotoxicity results, evaluated the anti-inflammatory potential of the ethyl acetate fraction of Striga hermonthica (EtOAc-Sh) in AGE-challenged THP-1 monocytes. The in vitro methylglyoxal (MGO)-bovine serum albumin (BSA) assay revealed notable inhibition of AGE formation by EtOAc-Sh (IC50 = 100.1 ± 0.001 μg/mL; quercetin 1.23 μM, gallic acid 0.131 μM, rutin 0.0021 μM), with rutin used as the standard (IC50 = 402 ± 0.30 μM). Cell metabolic assay showed EtOAc-Sh was non-cytotoxic to HepG2 hepatocytes (∼ 94 % cell viability at 250 μg/mL), and THP-1 monocytes (≥ 90 % cell viability at 500 μg/mL). Moreover, EtOAc-Sh significantly (p < 0.001) reduced the AGE-mediated ROS production (83 % at 100 μg/mL), as compared to apocynin (69 % at 100 μM). Furthermore, EtOAc-Sh suppressed the NF-κB (p65) (RFU: 9.18 at 100 μg/mL) activation, as compared to PDTC (RFU: 6.97) at 100 μM. EtOAc-Sh also significantly (p < 0.001) reduced the COX-2 levels (1.52-fold decrease at 100 μg/mL; PDTC, 1.68-fold decrease) in THP-1 monocytes, while significantly (p < 0.001) reversing the AGE-induced suppression of COX-1 levels (1.89-fold increase at 100 μg/mL; PDTC, 1.88-fold increase) at 100 μM. HPLC-UV analysis identified quercetin, gallic acid, and rutin, as the active constituents of the EtOAc-Sh fraction. These findings suggest that EtOAc-Sh fraction as a potential antiglycation, and anti-inflammatory agent, which supporting the traditional use of Striga hermonthica in diabetes management in Burkina Faso.
扫码关注我们
求助内容:
应助结果提醒方式:
